Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Ani Pharmaceuticals revenue
Ani Pharmaceuticals's revenue is $614.4 million.
What is Ani Pharmaceuticals's revenue?
- Ani Pharmaceuticals's revenue growth from 2003 to 2024 is 937,964.56%.
- Ani Pharmaceuticals has 601 employees, and the revenue per employee ratio is $1,022,256.
- Ani Pharmaceuticals's peak quarterly revenue was $190.6M in 2024(q4).
- Ani Pharmaceuticals peak revenue was $614.4M in 2024.
- Ani Pharmaceuticals annual revenue for 2023 was 486.8M, 53.87% growth from 2022.
- Ani Pharmaceuticals annual revenue for 2024 was 614.4M, 26.2% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Ani Pharmaceuticals historical revenue
Ani Pharmaceuticals's peak revenue was $614.4M in 2024. The peak quarterly revenue was $190.6M in 2024(q4).
Ani Pharmaceuticals's revenue increased from $65.5k in 2003 to $614.4M currently. That's a 937,964.56% change in annual revenue.
Ani Pharmaceuticals annual revenue
Ani Pharmaceuticals annual revenue over time
| Fiscal year / year | Ani Pharmaceuticals revenue |
|---|---|
| 2009 | $1.3M |
| 2010 | $2.5M |
| 2011 | $435,160 |
| 2012 | $20.4M |
| 2013 | $30.1M |
| 2014 | $56.0M |
| 2015 | $76.3M |
| 2016 | $128.6M |
| 2017 | $176.8M |
| 2018 | $201.6M |
| 2019 | $206.5M |
| 2020 | $208.5M |
| 2021 | $216.1M |
| 2022 | $316.4M |
| 2023 | $486.8M |
| 2024 | $614.4M |
How accurately did Ani Pharmaceuticals' revenue projections match actual performance?
Ani Pharmaceuticals annual growth
Ani Pharmaceuticals saw the greatest revenue growth in 2006, when revenue increased by 5,488.76%.
Ani Pharmaceuticals had the lowest revenue growth in 2007, when revenue changed by -96.59%.
Ani Pharmaceuticals annual growth rate over time
| Year | Ani Pharmaceuticals growth |
|---|---|
| 2009 | -67%↓ |
| 2010 | 97%↑ |
| 2011 | -82%↓ |
| 2012 | 4581%↑ |
| 2013 | 48%↑ |
| 2014 | 86%↑ |
| 2015 | 36%↑ |
| 2016 | 69%↑ |
| 2017 | 37%↑ |
| 2018 | 14%↑ |
| 2019 | 2%↑ |
| 2020 | 1%↑ |
| 2021 | 4%↑ |
| 2022 | 46%↑ |
| 2023 | 54%↑ |
| 2024 | 26%↑ |
Ani Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Ani Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $68,428 | $115,163 | $10,492 | $1.1M |
| 2010 | $2.3M | - | $51,331 | $143,032 |
| 2011 | $57,000 | $81,003 | $182,784 | $114,373 |
| 2012 | $114,000 | $108,878 | $110,204 | $2.0M |
| 2013 | $144,991 | $6.2M | $7.8M | $10.5M |
| 2014 | $10.9M | $6.6M | $17.4M | $21.0M |
| 2015 | $18.8M | $19.5M | $20.0M | $18.0M |
| 2016 | $20.6M | $31.3M | $38.5M | $38.2M |
| 2017 | $36.6M | $44.8M | $48.2M | $47.3M |
| 2018 | $46.5M | $47.3M | $50.7M | $57.1M |
| 2019 | $52.9M | $54.4M | $51.3M | $48.0M |
| 2020 | $49.8M | $48.5M | $53.0M | $57.3M |
| 2021 | $54.5M | $48.6M | $52.1M | $60.9M |
| 2022 | $64.5M | $73.9M | $83.8M | $94.2M |
| 2023 | $106.8M | $116.5M | $131.8M | $131.7M |
| 2024 | $137.4M | $138.0M | $148.3M | $190.6M |
Ani Pharmaceuticals jobs nearby
Do you work at Ani Pharmaceuticals?
Did Ani Pharmaceuticals meet its revenue projections?
Ani Pharmaceuticals financial information
| CEO | Nikhil Lalwani |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 601 |
| Date Founded | 1996 |
| Headquarters | Baudette, Minnesota |
| Number of Locations | 1 |
| Revenue | $614.4M |
| Net Income | -$47,896,000 |
| Gross Proft | $364.2M (2024) |
| EBITDA | $63.1M (2024) |
| PE Ratio | -35.50 |
| Tax Rate | 0.2% |
| Market Capitalization | $657.6M |
| Total Assets | $760,087,000 |
| Ticker | ANIP |
Ani Pharmaceuticals jobs you might like
Ani Pharmaceuticals financing
Ani Pharmaceuticals received early financing of $125.0M on 2017-12-29.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Debt | $125M | 12/2017 |
| Post Ipo Equity | $75M | 11/2021 |
Ani Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Citizens Financial Group, Inc. | Post Ipo Debt |
Ani Pharmaceuticals competitors
Ani Pharmaceuticals's top competitor, Ivax Research, earned an annual revenue of $2.2B.
Ani Pharmaceuticals's smallest competitor is KVK Tech with revenue of $1.7M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Impax Laboratories | $54,971 | $775.8M | 1,257 | - |
| PharmaForce Inc. | $64,582 | $6.5M | 84 | - |
| Ivax Research | $58,757 | $2.2B | 10,100 | - |
| Tris Pharma | $67,691 | $102.0M | 200 | 13 |
| Par Pharmaceutical Inc | $61,975 | $260.0M | 400 | - |
| Caraco Pharmaceutical Laboratories | $60,574 | - | - | - |
| US Pharma Lab | $58,258 | $202.0M | 150 | 264 |
| Nesher Pharmaceuticals | $73,701 | $315.3M | 124 | - |
| Watson Laboratories | $65,919 | $37.0M | 50 | - |
| KVK Tech | $65,172 | $1.7M | 20 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Ani Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Ani Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ani Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Ani Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ani Pharmaceuticals. The data presented on this page does not represent the view of Ani Pharmaceuticals and its employees or that of Zippia.
Ani Pharmaceuticals may also be known as or be related to ANI PHARMACEUTICALS INC, ANI Pharmaceuticals, ANI Pharmaceuticals Inc, ANI Pharmaceuticals, Inc., Ani Pharmaceuticals and Ani Pharmaceuticals, Inc.